A great way to close a very productive year with our work as cover page of the Journal of Cerebral Blood Flow and Metabolism, December 2017. The journal highlights our multimodal-multiresolution PET-MRI method for myelin mapping in vivo in controls and MS patients (Grecchi et al, 2017)
Graphics and Design by Federico Baratto.
British scientists have begun testing a radically new approach to treating schizophrenia based on emerging evidence that it could be a disease of the immune system […]
Take part in a Wellcome Trust funded research study (http://www.neuroimmunology.org.uk/take-part) investigating the biology of depression and in particular the little understood link between inflammation and depression. This is a new and exciting area of mental health research and you can help us by taking part.
We are looking for people aged 25-50, who are currently experiencing depressive symptoms, and also people who have never had depression to take part in BIODEP.
Eligible participants will be asked to have blood tests, interviews, and an MRI scan. There is also an optional PET Scan and an optional Lumbar Puncture procedure to take part in. All participants will be substantially reimbursed, with travel and food costs included.
Video Credit: BBC News
Welcome to Molecular Section of the Neuroimaging Department at King’s College London. Through this web portal we wish to share our most recent research work and methods on molecular neuroimaging.
Our research portfolio ranges from the development and validation of biomarkers for the in-vivo imaging of the brain in health and disease to the definition of novel methods for imaging data analysis and statistics. This includes the synergetic combination of molecular imaging modalities like PET, SPECT and autoradiography with more conventional neuroimaging methods like MRI and EEG.
The work is done in collaboration with many national and international partners in Europe and overseas.
